Pre-made benchmark antibody with INN name
Virus-like particles (VLP) Platforms for immunogens, vaccines and drug carriers
Antibody-drug Conjugate (ADC): Pre-made ADC benchmark, MOA, Production and QC
Neutralizing antibodies of virus (SARS2, HIV, HBV, Rabies, RSV, Ebola, Influenza)
Immunoglobulin Fc receptors for Fc&Fc Receptor binding assay
ILIBRA-HuEasy Monoclonal antibody (mab) humanization service (fully humanized ab)
Single domain antibody (Nanobody)
SOCAIL MEDIA
GeneMedi provides pre-made research class therapeutic antibodies & Fusion Protein with WHO-INN name. The INN named antibodies & Fusion Protein are biosimilars expressed by mammalian cell line as a benchmark reference therapeutic antibody or Fusion Protein for cell culture, in vitro/in vivo assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Link to IMGT(Immunogenetics Information System)
Know more about INN named antibodies
Download about 
INN information from WHO
Product list
Filters
Sort results
Reset
Apply
Cat No. | Products Name (INN Index) | INN Name | Previous Name | Target | Format | Order |
|---|---|---|---|---|---|---|
Pre-Made Iodo (124I) Girentuximab Biosimilar, Radiolabelled Antibody, Anti-CA9/CA-IX Antibody: Anti-CAIX/MN therapeutic antibody |
iodo (124I) girentuximab |
NA |
CA9 |
Radiolabelled antibody |
||
Pre-Made Ipafricept biosimilar, Fusion Protein: Recombinant therapeutic protein targeting Wnt fused with human IGHG1 Fc (Fragment constant) |
ipafricept |
NA |
Wnt |
Fusion Protein |
||
Pre-Made Izokibep Biosimilar, Bispecific, Anti-ALB;IL17A/IL17 Antibody: Anti-FDAHT/HSA/PRO0883/PRO0903/PRO1341;CTLA-8/CTLA8A therapeutic antibody |
izokibep |
NA |
ALB,IL17A |
trivalent bispecific |
||
Pre-Made Keliximab Biosimilar, Whole Mab, Anti-Cd4 Antibody: Anti-IMD79/OKT4D therapeutic antibody |
keliximab |
NA |
CD4 |
Whole mAb |
||
Pre-Made Labetuzumab Govitecan Biosimilar, Whole Mab Adc, Anti-CEACAM5/CD66e Antibody: Anti-CEA therapeutic antibody Drug Conjugate |
labetuzumab govitecan |
NA |
CEACAM5 |
Whole mAb ADC |
||
Pre-Made Ladiratuzumab Vedotin Biosimilar, Whole Mab Adc, Anti-Slc39A6 Antibody: Anti-LIV-1/LIV1/ZIP6 therapeutic antibody Drug Conjugate |
ladiratuzumab vedotin |
NA |
SLC39A6 |
Whole mAb ADC |
||
Pre-Made Laprituximab Emtansine Biosimilar, Whole Mab Adc, Anti-Egfr Antibody: Anti-ERBB/ERBB1/ERRP/HER1/NISBD2/PIG61/mENA therapeutic antibody Drug Conjugate |
laprituximab emtansine |
NA |
EGFR |
Whole mAb ADC |
||
Pre-Made Ledelabricin Alfa biosimilar, Recombinant Protein: Recombinant therapeutic protein targeting PRG4(PROTEOGLYCAN 4) |
ledelabricin alfa |
NA |
PRG4(PROTEOGLYCAN 4) |
Recombinant Protein |
||
Pre-Made Lemalesomab Biosimilar, Whole Mab: Anti-Nca-90 (Nonspecific Cross- Reacting Antigens 90Kda Glycoproteins, Granulocyte Cell Antigen) [human] therapeutic antibody |
lemalesomab |
NA |
NCA-90 (nonspecific cross- reacting antigens 90kDa glycoproteins, granulocyte cell antigen) [Homo sapiens] |
Whole mAb |
||
Pre-Made Lenercept Biosimilar, Fusion Protein targeting TNF fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting DIF/TNFSF2/TNLG1F |
lenercept |
NA |
TNF |
Fusion Protein |
||
Pre-Made Lepunafusp Alfa Biosimilar, Fusion Protein targeting TFRC fused with human IDUA (iduronidase, alpha-L-) isoform 1 via a peptidyl linker: Recombinant therapeutic protein targeting CD71/IMD46/ |
lepunafusp alfa |
NA |
TFRC |
Fusion Protein |
||
Pre-Made Lerdelimumab Biosimilar, Whole Mab, Anti-Tgfb2 Antibody: Anti-G-TSF/LDS4/TGF-beta2 therapeutic antibody |
lerdelimumab |
NA |
TGFB2 |
Whole mAb |
||
Pre-Made Lerodalcibep Biosimilar, Fusion Protein targeting PCSK9 fused with ALB (albumin, human serum albumin, HSA): Recombinant therapeutic protein targeting FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC |
lerodalcibep |
NA |
PCSK9 |
Fusion Protein |
||
Pre-Made Libivirumab Biosimilar, Whole Mab: Anti-Hbv (Hepatitis B Virus) Surface Antigen (Hbsag) [Hepatitis B Virus] therapeutic antibody |
libivirumab |
NA |
HBV (hepatitis B virus) surface antigen (HBsAg) [Hepatitis B virus] |
Whole mAb |
||
Pre-Made Lifastuzumab Vedotin Biosimilar, Whole Mab Adc, Anti-Slc34A2 Antibody: Anti-NAPI-3B/NAPI-IIb/NPTIIb/PULAM therapeutic antibody Drug Conjugate |
lifastuzumab vedotin |
NA |
SLC34A2 |
Whole mAb ADC |
||
Pre-Made Loncastuximab Tesirine Biosimilar, Whole Mab Adc, Anti-Cd19 Antibody: Anti-B4/CVID3 therapeutic antibody Drug Conjugate |
loncastuximab tesirine |
NA |
CD19 |
Whole mAb ADC |
||
Pre-Made Lonigutamab Ugodotin Biosimilar, Whole Mab Adc, Anti-Igf1R Antibody: Anti-CD221/IGFIR/IGFR/JTK13 therapeutic antibody Drug Conjugate |
lonigutamab ugodotin |
NA |
IGF1R |
Whole mAb ADC |
||
Pre-Made Lorukafusp Alfa biosimilar, Fusion Protein: Recombinant therapeutic protein targeting ganglioside GD2 fused with human IL2 (interleukin 2, IL-2) |
lorukafusp alfa |
NA |
Ganglioside GD2 |
Fusion Protein |
||
Pre-Made Lorvotuzumab Mertansine Biosimilar, Whole Mab Adc, Anti-Ncam1 Antibody: Anti-CD56/MSK39/NCAM therapeutic antibody Drug Conjugate |
lorvotuzumab mertansine |
NA |
NCAM1 |
Whole mAb ADC |
||
Pre-Made Losatuxizumab Vedotin Biosimilar, Whole Mab Adc, Anti-Egfr Antibody: Anti-ERBB/ERBB1/ERRP/HER1/NISBD2/PIG61/mENA therapeutic antibody Drug Conjugate |
losatuxizumab vedotin |
NA |
EGFR |
Whole mAb ADC |
||
Pre-Made Lupartumab Amadotin Biosimilar, Whole Mab Adc, Anti-Lypd3 Antibody: Anti-C4.4A therapeutic antibody Drug Conjugate |
lupartumab amadotin |
NA |
LYPD3 |
Whole mAb ADC |
||
Pre-Made Luspatercept Biosimilar, Fusion Protein targeting GDF11 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting BMP-11/BMP11/VHO |
luspatercept |
NA |
GDF11 |
Fusion Protein |
||
Pre-Made Lutetium (177Lu) Lilotomab Satetraxetan Biosimilar, Radiolabelled Antibody, Anti-Cd37 Antibody: Anti-GP52-40/TSPAN26 therapeutic antibody |
lutetium (177lu) lilotomab satetraxetan |
NA |
CD37 |
Radiolabelled antibody |
||
Pre-Made Mapatumumab Biosimilar, Whole Mab, Anti-TNFRSF10A/TRAIL-R1 Antibody: Anti-APO2/CD261/DR4/TRAILR-1/TRAILR1 therapeutic antibody |
mapatumumab |
NA |
TNFRSF10A |
Whole mAb |
||
Pre-Made Maslimomab Biosimilar, Whole Mab: Anti-T Cell Receptor (Tr, Tr Alpha_Beta) [human] therapeutic antibody |
maslimomab |
NA |
T cell receptor (TR, TR alpha_beta) [Homo sapiens] |
Whole mAb |
||
Pre-Made Melredableukin Alfa Biosimilar, Fusion Protein targeting IL2RA fused with human IL2 (interleukin 2, IL-2) via a peptidyl linker: Recombinant therapeutic protein targeting CD25/IDDM10/IL2R/IM |
melredableukin alfa |
NA |
IL2RA |
Fusion Protein |
||
Pre-Made Metelimumab Biosimilar, Whole Mab, Anti-Tgfb1 Antibody: Anti-CED/DPD1/IBDIMDE/LAP therapeutic antibody |
metelimumab |
NA |
TGFB1 |
Whole mAb |
||
Pre-Made Minretumomab Biosimilar, Whole Mab: Anti-Tag-72 therapeutic antibody |
minretumomab |
NA |
TAG-72 |
Whole mAb |
||
Pre-Made Mipasetamab Uzoptirine Biosimilar, Whole Mab Adc, Anti-Axl Antibody: Anti-ARK/JTK11/Tyro7/UFO therapeutic antibody Drug Conjugate |
mipasetamab uzoptirine |
NA |
AXL |
Whole mAb ADC |
||
Pre-Made Mirococept biosimilar, Recombinant Protein targeting C3b/C4b: Recombinant therapeutic protein |
mirococept |
NA |
C3b/C4b |
Recombinant Protein |
||
Pre-Made Mirvetuximab Soravtansine Biosimilar, Whole Mab Adc, Anti-Folr1 Antibody: Anti-FBP/FOLR/FRalpha/NCFTD therapeutic antibody Drug Conjugate |
mirvetuximab soravtansine |
NA |
FOLR1 |
Whole mAb ADC |
||
Pre-Made Mirzotamab Clezutoclax Biosimilar, Whole Mab Adc, Anti-Cd276 Antibody: Anti-4Ig-B7-H3/B7-H3/B7H3/B7RP-2 therapeutic antibody Drug Conjugate |
mirzotamab clezutoclax |
NA |
CD276 |
Whole mAb ADC |
||
Pre-Made Mitumomab Biosimilar, Whole Mab: Anti-Ganglioside Gd3 therapeutic antibody |
mitumomab |
NA |
ganglioside GD3 |
Whole mAb |
||
Pre-Made Modakafusp Alfa Biosimilar, Fusion Protein targeting CD38 fused with human IFNA2 (interferon alpha 2) *b (R46,H57) 24-188: Recombinant therapeutic protein targeting ADPRC 1/ADPRC1 |
modakafusp alfa |
NA |
CD38 |
Fusion Protein |
||
Pre-Made Morolimumab Biosimilar, Whole Mab, Anti-Rhd Antibody: Anti-CD240D/DIIIc/HDFNRH/RH/RH30/RHCED/RHDVA(TT)/RHDel/RHPII/RHXIII/Rh4/RhDCw/RhII/RhK562-II/RhPI therapeutic antibody |
morolimumab |
NA |
RHD |
Whole mAb |
||
Pre-Made Moxetumomab Pasudotox biosimilar, Fusion Protein, Moxetumomab-Anti-CD22 Antibody: Anti-SIGLEC-2/SIGLEC2 therapeutic antibody fused with Pseudomonas aeruginosa exotoxin A |
moxetumomab pasudotox |
NA |
CD22 |
Fusion Protein |
||
Pre-Made Muromonab-Cd3 3Iosimilar, Whole Mab, Anti-Cd3E Antibody: Anti-CD3epsilon/IMD18/T3E/TCRE therapeutic antibody |
muromonab-CD3 |
NA |
CD3E |
Whole mAb |
||
Pre-Made Nacolomab Tafenatox biosimilar, Fusion Protein, Nacolomab-Anti-MUC1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therape |
nacolomab tafenatox |
NA |
MUC1 |
Fusion Protein |
||
Pre-Made Naptumomab Estafenatox biosimilar, Fusion Protein, Naptumomab-Anti-TPBG Antibody: Anti-5T4/5T4AG/M6P1/WAIF1 therapeutic antibody fused with Staphylococcus aureus enterotoxin E SEA/E120 super |
naptumomab estafenatox |
NA |
TPBG |
Fusion Protein |
||
Pre-Made Naratuximab Emtansine Biosimilar, Whole Mab Adc, Anti-Cd37 Antibody: Anti-GP52-40/TSPAN26 therapeutic antibody Drug Conjugate |
naratuximab emtansine |
NA |
CD37 |
Whole mAb ADC |
||
Pre-Made Nebacumab Biosimilar, Whole Mab: Anti-Endotoxin (Lipid A, Domain Of Lipopolyaccharide, Lps) [Gram Negative Bacteria] therapeutic antibody |
nebacumab |
NA |
endotoxin (lipid A, domain of lipopolyaccharide, LPS) [gram negative bacteria] |
Whole mAb |
||
Pre-Made Nemvaleukin Alfa Biosimilar, Fusion Protein targeting IL2RA fused with human IL2RA (interleukin 2 receptor alpha subunit, IL-2RA, TAC, p55, CD25) 139-303 (1-165): Recombinant therapeutic pro |
nemvaleukin alfa |
NA |
IL2RA |
Fusion Protein |
||
Pre-Made Nerelimomab Biosimilar, Whole Mab, Anti-Tnf Antibody: Anti-DIF/TNFSF2/TNLG1F therapeutic antibody |
nerelimomab |
NA |
TNF |
Whole mAb |
||
Pre-Made Nogapendekin Alfa Biosimilar, Recombinant Protein targeting IL15RA: Recombinant therapeutic protein targeting CD215 |
nogapendekin alfa |
NA |
IL15RA |
Recombinant Protein |
||
Pre-Made Nonacog Gamma Biosimilar, Recombinant Protein targeting F9: Recombinant therapeutic protein targeting FIX/P19/PTC/HEMB/THPH8 |
nonacog gamma |
NA |
F9 |
Recombinant Protein |
||
Pre-Made Odulimomab Biosimilar, Fab Fusion, Anti-Itgal Antibody: Anti-CD11A/LFA-1/LFA1A therapeutic antibody |
odulimomab |
NA |
ITGAL |
Fab Fusion |
||
Pre-Made Olamkicept Biosimilar, Fusion Protein targeting IL6 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6 |
olamkicept |
NA |
IL6 |
Fusion Protein |
||
Pre-Made Omfiloctocog Alfa Biosimilar, Recombinant Protein targeting F8: Recombinant therapeutic protein targeting AHF/F8B/F8C/HEMA/FVIII/DXS1253E |
omfiloctocog alfa |
NA |
F8 |
Recombinant Protein |
||
Pre-Made Onercept Biosimilar, Recombinant Protein targeting TNF: Recombinant therapeutic protein targeting DIF/TNFSF2/TNLG1F |
onercept |
NA |
TNF |
Recombinant Protein |
||
Pre-Made Onfekafusp Alfa Biosimilar, Fusion Protein targeting FN/FN1 fused with human TNF (tumor necrosis factor (TNF) superfamily member 2, TNFSF2, TNF-alpha, TNFA) - trimer: Recombinant therapeutic |
onfekafusp alfa |
NA |
FN |
Fusion Protein |
